Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5558203

C[N+](C)(C)CC(=O)Cl.[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL138865 0.97
Ammonia Solution, Strong SCHEMBL28052971 0.94
Monoethanolamine SCHEMBL20360727 0.82 TSHR (0.40)
SCHEMBL26395722 0.73 TSHR (0.36)
Betaine SCHEMBL59207 0.71
Hydrochloric Acid SCHEMBL28343100 0.71
Hydrochloric Acid SCHEMBL9096616 0.71 ALDH1A1 (0.50)
SCHEMBL12557080 0.69 TSHR (0.59)
SCHEMBL8742965 0.69 TSHR (0.43)
Betaine SCHEMBL9183983 0.69 LMNA (0.94)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3017307-B1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING UNIV STRASBOURG (FR) 2018-11-21 EP disclosed
US-10131626-B2 3-aryl propiolonitrile compounds for thiol labeling UNIVERSITE DE STRASBOURG (FR) 2018-11-20 US disclosed
US-20170210700-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-07-27 US disclosed
US-9663454-B2 3-aryl propiolonitrile compounds for thiol labeling UNIVERSITE DE STRASBOURG (FR) 2017-05-30 US disclosed
US-20160145199-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING UNIVERSITE DE STRASBOURG (FR) 2016-05-26 US disclosed
EP-3017307-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING Université de Strasbourg (FR) 2016-05-11 EP disclosed
WO-2015001117-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING UNIVERSITE DE STRASBOURG (FR) 2015-01-08 WO disclosed
EP-1453502-A4 PHARMACEUTICAL FORMULATIONS COMPRISING INDOLINONE DERIVATIVES SUGEN INC (US) 2007-01-10 EP disclosed
US-7112603-B2 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives AGOURON PHARMACEUTICALS, INC. (US) 2006-09-26 US disclosed
US-7109185-B2 Pharmaceutical formulations comprising indolinone derivatives SUGEN, INC. (US) 2006-09-19 US disclosed
EP-1453502-A2 PHARMACEUTICAL FORMULATIONS COMPRISING INDOLINONE DERIVATIVES Sugen, Inc. (US) 2004-09-08 EP disclosed
US-6716870-B2 PROTEIN KINASE MODULATORS SUGEN, INC. 2004-04-06 US disclosed
US-20030176399-A1 Pharmaceutical formulations comprising indolinone derivatives SUGEN INCORPORATED 2003-09-18 US disclosed
WO-2003045307-A2 PHARMACEUTICAL FORMULATIONS COMPRISING INDOLINONE DERIVATIVES SUGEN, INC. (US) 2003-06-05 WO disclosed
US-20030083363-A1 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives SUGEN INCORPORATED 2003-05-01 US disclosed
EP-1283835-A2 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS Sugen, Inc. (US) 2003-02-19 EP disclosed
US-6482848-B2 KINASE INHIBITORS SUGEN INCORPORATED 2002-11-19 US disclosed
US-20020037878-A1 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives PHARMACIA & UPJOHN COMPANY 2002-03-28 US disclosed
WO-2001090103-A9 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS SUGEN INC (US) 2002-03-07 WO disclosed
WO-2001090103-A2 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS SUGEN, INC. (US) 2001-11-29 WO disclosed